91制片厂

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it鈥檚 official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you鈥檙e on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 10
1946 53
1947 79
1948 63
1949 53
1950 1
1954 1
1955 5
1956 6
1957 1
1958 7
1959 2
1960 1
1961 2
1962 1
1963 6
1964 8
1965 9
1966 6
1967 7
1968 7
1969 18
1970 15
1971 25
1972 22
1973 26
1974 45
1975 106
1976 105
1977 136
1978 176
1979 206
1980 204
1981 261
1982 289
1983 355
1984 398
1985 484
1986 575
1987 638
1988 739
1989 837
1990 899
1991 974
1992 1158
1993 1242
1994 1355
1995 1572
1996 1713
1997 1826
1998 2045
1999 2275
2000 2487
2001 2632
2002 2937
2003 3111
2004 3604
2005 4066
2006 4302
2007 4745
2008 5059
2009 5543
2010 6273
2011 6867
2012 7782
2013 8256
2014 9186
2015 9875
2016 10082
2017 10504
2018 11171
2019 12215
2020 13807
2021 14953
2022 15068
2023 14521
2024 11452
2025 7

Text availability

Article attribute

Article type

Publication date

Search Results

200,253 results

Results by year

Filters applied: . Clear all
Page 1
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms.
Chu X, Li X, Zhang Y, Dang G, Miao Y, Xu W, Wang J, Zhang Z, Cheng S. Chu X, et al. Nat Cancer. 2024 Sep;5(9):1409-1426. doi: 10.1038/s43018-024-00807-z. Epub 2024 Aug 15. Nat Cancer. 2024. PMID: 39147986
The tumor microenvironment (TME) considerably influences colorectal cancer (CRC) progression, therapeutic response and clinical outcome, but studies of interindividual heterogeneities of the TME in CRC are lacking. ...
The tumor microenvironment (TME) considerably influences colorectal cancer (CRC) progression, therapeutic response and clinica 鈥�
CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis.
Zhang Y, Liu G, Zeng Q, Wu W, Lei K, Zhang C, Tang M, Zhang Y, Xiang X, Tan L, Cui R, Qin S, Song X, Yin C, Chen Z, Kuang M. Zhang Y, et al. Cancer Cell. 2024 Aug 12;42(8):1370-1385.e9. doi: 10.1016/j.ccell.2024.07.006. Cancer Cell. 2024. PMID: 39137726
However, their formation and functions in colorectal cancer liver metastasis (CRLM) remain unclear. Here, we reveal that intra- and peri-tumor mature TLSs (TLS+) are associated with improved clinical outcomes than TLS- tumors. ...As the proof-of-concept, we demonstr 鈥�
However, their formation and functions in colorectal cancer liver metastasis (CRLM) remain unclear. Here, we reveal that intra 鈥�
Menin in Cancer.
Majer AD, Hua X, Katona BW. Majer AD, et al. Genes (Basel). 2024 Sep 21;15(9):1231. doi: 10.3390/genes15091231. Genes (Basel). 2024. PMID: 39336822 Free PMC article. Review.
On the other hand, menin can also serve as a tumor promoter in leukemia, colorectal cancer, ovarian and endometrial cancers, Ewing sarcoma, and gliomas. Moreover, menin can either suppress or promote tumorigenesis in the breast and prostate depending on hormone rece 鈥�
On the other hand, menin can also serve as a tumor promoter in leukemia, colorectal cancer, ovarian and endometrial cancers, E 鈥�
Ponsegromab for the Treatment of Cancer Cachexia.
Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, Hendifar AE, Fallon M, Takayama K, Asmis T, Dunne RF, Karahanoglu I, Northcott CA, Harrington MA, Rossulek M, Qiu R, Saxena AR. Groarke JD, et al. N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMoa2409515. Online ahead of print. N Engl J Med. 2024. PMID: 39282907
Of these patients, 40% had non-small-cell lung cancer, 32% had pancreatic cancer, and 29% had colorectal cancer. At 12 weeks, patients in the ponsegromab groups had significantly greater weight gain than those in the placebo group, with a median between-group differ 鈥�
Of these patients, 40% had non-small-cell lung cancer, 32% had pancreatic cancer, and 29% had colorectal cancer. At 12 weeks, 鈥�
Early diagnostic strategies for colorectal cancer.
Liu SC, Zhang H. Liu SC, et al. World J Gastroenterol. 2024 Sep 7;30(33):3818-3822. doi: 10.3748/wjg.v30.i33.3818. World J Gastroenterol. 2024. PMID: 39351429 Free PMC article.
At present, cancer is still an important factor threatening human health. Colorectal cancer (CRC) is one of the top three most common cancers worldwide and one of the deadliest malignancies in humans. ...
At present, cancer is still an important factor threatening human health. Colorectal cancer (CRC) is one of the top three most 鈥�
NLRC4, inflammation and colorectal cancer (Review).
Tong G, Shen Y, Li H, Qian H, Tan Z. Tong G, et al. Int J Oncol. 2024 Oct;65(4):99. doi: 10.3892/ijo.2024.5687. Epub 2024 Sep 6. Int J Oncol. 2024. PMID: 39239759 Free PMC article. Review.
The present review summarizes the role of Nod-like receptor C4 (NLRC4) in inflammation and colorectal cancer (CRC). Reviews of the literature were conducted using Web of Science, 91制片厂 and CNKI, with search terms including 'NLRC4', 'colorectal cancer' 鈥�
The present review summarizes the role of Nod-like receptor C4 (NLRC4) in inflammation and colorectal cancer (CRC). Reviews of 鈥�
Targeting m7G-enriched circKDM1A prevents colorectal cancer progression.
Sun Z, Xu Y, Si C, Wu X, Guo Y, Chen C, Wang C. Sun Z, et al. Mol Cancer. 2024 Aug 30;23(1):179. doi: 10.1186/s12943-024-02090-z. Mol Cancer. 2024. PMID: 39215345 Free PMC article.
Plenty of circRNAs have been reported to play an important role in colorectal cancer (CRC), while the reason of abnormal circRNA expression in cancer still keep elusive. ...
Plenty of circRNAs have been reported to play an important role in colorectal cancer (CRC), while the reason of abnormal circR 鈥�
Recent Updates on PRDM2 in Colorectal Cancer.
Di Zazzo E, Rienzo M, Casamassimi A, Gazzerro P, Abbondanza C. Di Zazzo E, et al. Front Biosci (Landmark Ed). 2024 Sep 4;29(9):316. doi: 10.31083/j.fbl2909316. Front Biosci (Landmark Ed). 2024. PMID: 39344327 Free article. Review. No abstract available.
Li-Fraumeni Syndrome.
Schneider K, Zelley K, Nichols KE, Schwartz Levine A, Garber J. Schneider K, et al. 1999 Jan 19 [updated 2024 Sep 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews庐 [Internet]. Seattle (WA): University of Washington, Seattle; 1993鈥�2024. 1999 Jan 19 [updated 2024 Sep 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews庐 [Internet]. Seattle (WA): University of Washington, Seattle; 1993鈥�2024. PMID: 20301488 Free Books & Documents. Review.
Other cancers associated with LFS include leukemia, colorectal cancer, stomach cancer, lung cancer, melanoma, pediatric head and neck cancers, pancreatic cancer, and prostate cancer. ...Prevention of primary manifestations: Risk-reducing bilateral mastectomy to redu 鈥�
Other cancers associated with LFS include leukemia, colorectal cancer, stomach cancer, lung cancer, melanoma, pediatric head a 鈥�
Colorectal cancer cell dormancy: An insight into pathways.
Kumar A, Saha L. Kumar A, et al. World J Gastroenterol. 2024 Sep 7;30(33):3810-3817. doi: 10.3748/wjg.v30.i33.3810. World J Gastroenterol. 2024. PMID: 39351431 Free PMC article.
Cancer cell dormancy (CCD) in colorectal cancer (CRC) poses a significant challenge to effective treatment. In CRC, CCD contributes to tumour recurrence, drug resistance, and amplifying the disease's burden. ...
Cancer cell dormancy (CCD) in colorectal cancer (CRC) poses a significant challenge to effective treatment. In CRC, CCD contri 鈥�
200,253 results
You have reached the last available page of results. Please see the User Guide for more information.